Evidence map›Paper›PMID 34465357›Full record

Trial reportCritical care (London, England)2021

Comprehensive versus standard care in post-severe acute kidney injury survivors, a randomized controlled trial.

Peerapat Thanapongsatorn, Kamolthip Chaikomon, Nuttha Lumlertgul, Khanitha Yimsangyad, Akarathep Leewongworasingh, Win Kulvichit, Phatadon Sirivongrangson, Sadudee Peerapornratana, Weerachai Chaijamorn, Yingyos Avihingsanon and 1 more

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Critical care (London, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04012008 (Standard Versus Comprehensive Care for Post Acute Kidney Injury), which is not on this map. Cited by 35 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04012008 nacompletednot on this map

Standard Versus Comprehensive Care for Post Acute Kidney Injury: A Randomized Controlled Trial

TypeinterventionalSponsorChulalongkorn UniversityRan2019 to 2022Enrolled200ConditionsAcute Kidney InjuryArmsComprehensive care, Standard care
3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Review
  8. SGLT2 Inhibitors and Long-Term Outcomes After AKI.Kidney international reports · 2026
    Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Acute Kidney Injury in Care Transitions (ACT): A Randomized Controlled Feasibility Trial.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2025
    Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Peerapat Thanapongsatorn *Department of Medicine, Central Chest Institute of Thailand, Nonthaburi, Thailand.
Kamolthip Chaikomon *Lerdsin Hospital, Bangkok, Thailand.
Nuttha LumlertgulExcellence Center for Critical Care Nephrology, King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
Khanitha YimsangyadExcellence Center for Critical Care Nephrology, King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
Akarathep LeewongworasinghExcellence Center for Critical Care Nephrology, King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
Win KulvichitDepartment of Medicine, Central Chest Institute of Thailand, Nonthaburi, Thailand.
Phatadon SirivongrangsonDepartment of Medicine, Somdech Phra Pinklao Hospital, Bangkok, Thailand.
Sadudee PeerapornratanaExcellence Center for Critical Care Nephrology, King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
Weerachai ChaijamornFaculty of Pharmacy, Siam University, Bangkok, Thailand.
Yingyos AvihingsanonDivision of Nephrology, Department of Medicine, Faculty of Medicine, King Chulalongkorn Memorial Hospital, Bangkok, 10330, Thailand.
Nattachai SrisawatExcellence Center for Critical Care Nephrology, King Chulalongkorn Memorial Hospital, Bangkok, Thailand. drnattachai@yahoo.com.ORCID 0000-0002-8544-8132

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCurrently, there is a lack of evidence to guide optimal care for acute kidney injury (AKI) survivors. Therefore, post-discharge care by a multidisciplinary care team (MDCT) may improve these outcomes. This study aimed to demonstrate the outcomes of implementing comprehensive care by a MDCT in severe AKI survivors.

methodsThis study was a randomized controlled trial conducted between August 2018 to January 2021. Patients who survived severe AKI stage 2-3 were enrolled and randomized to be followed up with either comprehensive or standard care for 12 months. The comprehensive post-AKI care involved an MDCT (nephrologists, nurses, nutritionists, and pharmacists). The primary outcome was the feasibility outcomes; comprising of the rates of loss to follow up, 3-d dietary record, drug reconciliation, and drug alert rates at 12 months. Secondary outcomes included major adverse kidney events, estimated glomerular filtration rate (eGFR), and the amount of albuminuria at 12 months.

resultsNinety-eight AKI stage 3 survivors were enrolled and randomized into comprehensive care and standard care groups (49 patients in each group). Compared to the standard care group, the comprehensive care group had significantly better feasibility outcomes; 3-d dietary record, drug reconciliation, and drug alerts (p < 0.001). The mean eGFR at 12 months were comparable between the two groups (66.74 vs. 61.12 mL/min/1.73 m

conclusionsComprehensive care by an MDCT is feasible and could be implemented for severe AKI survivors. MDCT involvement also yields better reduction of the UACR and better blood pressure control. Trial registration Clinicaltrial.gov: NCT04012008 (First registered July 9, 2019).

Indexed as

Acute Kidney InjuryAgedAged, 80 and overFemaleHumansKidneyMaleMiddle AgedPatient DischargeProspective StudiesStatistics, NonparametricSurvivorsThailandAKI survivorsComprehensive careCritically ill patientsPost-acute kidney injurySevere AKI

Identifiers

PMID34465357
PMCPMC8406590

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.